News

Quetiapine in Bipolar Disorder: A Decade of Evidence
Jeannette Y. Wick, RPh, MBA, FASCP
The search for better treatment approaches has led clinicians to use atypical antipsychotics to augment or replace conventional approaches.
Meghan Ross, Associate Editor
Americans are feeling more responsible for their health, with 64% indicating in a national survey that they could be making more decisions about their health and wellness.
Krystle Vermes
The FDA is requesting more data on the safety and efficacy of certain health care antiseptic active ingredients.
The new health and wellness information resource will allow pharmacists to advance health conversations with their patients.
Meghan Ross, Associate Editor
Tricare made some changes that could affect the military community’s use of compound drugs.
Jeannette Y. Wick, RPh, MBA, FASCP
Thiazide diuretics are the least expensive antihypertensive drugs available in most countries.
Katie Eder, Senior Editor
Sandoz has introduced its ready-to-use levoleucovorin injection to the US market.
Meghan Ross, Associate Editor
Elevating the upper bodies of women who recently gave birth may help improve their respiratory safety.

Association News

The new health and wellness information resource will allow pharmacists to advance health conversations with their patients.
The House Armed Services Committee made revisions to a proposed “preferred pharmacy” pilot program for the military’s TRICARE health program.
NALOXONE ACCESS: A Practical Guideline for Pharmacists will be updated and maintained on the CPNP website as a freely available source of information.
These resources aim to improve transparency and consistency in the residency accreditation process and provide easily accessible training opportunities for residency programs.
NACDS also urges comprehensive approach to curbing prescription drug abuse that also ensures patient access.

Pharmacy Market News

There are no currently approved treatment options for adRP.
Jeff has served as Interim CFO since December 2014, while overseeing Investor Relations.
Increased offer consists of $75 per share in cash and 2.3 Mylan ordinary shares for each Perrigo ordinary share.

Strategic Alliance Partner News

$AD300x250BB$
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$